180 related articles for article (PubMed ID: 16329671)
1. Immunosuppressive treatment of chronic non-viral myocarditis.
Frustaci A; Pieroni M; Chimenti C
Ernst Schering Res Found Workshop; 2006; (55):343-51. PubMed ID: 16329671
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders.
Frustaci A; Chimenti C; Calabrese F; Pieroni M; Thiene G; Maseri A
Circulation; 2003 Feb; 107(6):857-63. PubMed ID: 12591756
[TBL] [Abstract][Full Text] [Related]
3. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.
Maisch B; Hufnagel G; Kölsch S; Funck R; Richter A; Rupp H; Herzum M; Pankuweit S
Herz; 2004 Sep; 29(6):624-36. PubMed ID: 15912438
[TBL] [Abstract][Full Text] [Related]
4. Lone hepatitis C virus myocarditis responsive to immunosuppressive therapy.
Frustaci A; Calabrese F; Chimenti C; Pieroni M; Thiene G; Maseri A
Chest; 2002 Oct; 122(4):1348-56. PubMed ID: 12377863
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive therapy in myocarditis.
Frustaci A; Chimenti C
Circ J; 2015; 79(1):4-7. PubMed ID: 25452202
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of dilated cardiomyopathies with and without inflammation].
Hufnagel G; Pankuweit S; Maisch B
Med Klin (Munich); 1998 Apr; 93(4):240-51. PubMed ID: 9594534
[TBL] [Abstract][Full Text] [Related]
8. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance.
Caforio AL; Mahon NJ; Tona F; McKenna WJ
Eur J Heart Fail; 2002 Aug; 4(4):411-7. PubMed ID: 12167378
[TBL] [Abstract][Full Text] [Related]
9. [Detection of enteroviral RNA in endomyocardial biopsies in inflammatory cardiomyopathy and idiopathic dilated cardiomyopathy].
Pauschinger M; Kühl U; Dörner A; Schieferecke K; Petschauer S; Rauch U; Schwimmbeck PL; Kandolf R; Schultheiss HP
Z Kardiol; 1998 Jun; 87(6):443-52. PubMed ID: 9691414
[TBL] [Abstract][Full Text] [Related]
10. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy.
Caforio AL; Mahon NJ; Mckenna WJ
Autoimmunity; 2001; 34(3):199-204. PubMed ID: 11908778
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory Cardiomyopathic Syndromes.
Trachtenberg BH; Hare JM
Circ Res; 2017 Sep; 121(7):803-818. PubMed ID: 28912184
[TBL] [Abstract][Full Text] [Related]
12. [Idiopathic dilated cardiomyopathy: a persistent viral infection or an organ-specific autoimmune disease? The trial of 2 major pathogenetic hypotheses].
Caforio AL; Bonifacio E; Keeling PJ; Grazzini M; Schiaffino S; Bottazzo GF; McKenna WJ
G Ital Cardiol; 1992 Jan; 22(1):63-72. PubMed ID: 1624070
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic myocarditis with corticosteroids.
Kühl U; Schultheiss HP
Eur Heart J; 1995 Dec; 16 Suppl O():168-72. PubMed ID: 8682089
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory dilated cardiomyopathy (DCMI).
Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
[TBL] [Abstract][Full Text] [Related]
15. [Efficiency of immunosuppressive therapy in virus-negative and virus-positive patients with morphologically verified lymphocytic myocarditis].
Blagova OV; Nedostup AV; Kogan EA; Sulimov VA
Ter Arkh; 2017; 89(8):57-67. PubMed ID: 28914852
[TBL] [Abstract][Full Text] [Related]
16. Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression.
Kleinert S; Weintraub RG; Wilkinson JL; Chow CW
J Heart Lung Transplant; 1997 Dec; 16(12):1248-54. PubMed ID: 9436137
[TBL] [Abstract][Full Text] [Related]
17. Implications of the Myocarditis Treatment Trial for clinical practice.
Brown CA; O'Connell JB
Curr Opin Cardiol; 1996 May; 11(3):332-6. PubMed ID: 8835876
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy.
Escher F; Kühl U; Lassner D; Poller W; Westermann D; Pieske B; Tschöpe C; Schultheiss HP
Clin Res Cardiol; 2016 Dec; 105(12):1011-1020. PubMed ID: 27312326
[TBL] [Abstract][Full Text] [Related]
19. Anti-heart autoantibodies in familial dilated cardiomyopathy.
Caforio AL; Vinci A; Iliceto S
Autoimmunity; 2008 Sep; 41(6):462-9. PubMed ID: 18781472
[TBL] [Abstract][Full Text] [Related]
20. Viral causes of human myocarditis.
Andréoletti L; Lévêque N; Boulagnon C; Brasselet C; Fornes P
Arch Cardiovasc Dis; 2009; 102(6-7):559-68. PubMed ID: 19664576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
